Leqembi (lecanemab-irmb)

Leqembi (lecanemab-irmb) is a humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody that responds against the amyloid-beta (Aβ) plaques prescribed to treat patients with Alzheimer's disease who present mild-stage cognitive impairment or dementia1.

  • Disease Indications : Alzheimer's disease
  • Manufacturer : Eisai Europe Ltd
  • Usage : Intravenous
Medicine approved by
  • Food and Drug Administration (FDA)
  • Pharmaceuticals and Medical Devices Agency (PMDA)